Rafael Holdings, Inc. Class B Common Stock (RFL)

Rafael Holdings Inc is a clinical-stage investment company that focuses on developing novel cancer therapies and related technologies

The company primarily invests in and supports early-stage biotech and pharmaceutical ventures, particularly those that are working on innovative treatment solutions targeting various types of cancer. In addition to its investments, Rafael Holdings is also engaged in the research and development of its own proprietary drug candidates, aiming to contribute to advancements in cancer treatment and improve patient outcomes through cutting-edge therapeutic approaches.